Electroactive nanostructured polypyrrole coatings with on-demand drug release for immunomodulation of neural electrode interfaces

Neural electrodes are central to a wide range of neuroprosthetic and neuromodulation technologies. However, persistent macrophage-driven inflammation often leads to fibrotic encapsulation and elevated electrical impedance, severely limiting stimulation efficiency and device longevity....

No actionable change for current clinical practice — this is early-stage materials science research with potential long-term implications for cochlear implant and neural prosthetic electrode longevity.

Reducing immune-driven inflammation at neural electrode interfaces is a fundamental challenge for cochlear implants and other auditory neuroprosthetics; advances in electrode coatings could eventually improve long-term implant performance.

1. 01Polypyrrole (an electrically-active polymer) was nanostructured into coatings for neural electrodes.
2. 02Coatings enable on-demand drug release triggered electrically, targeting macrophage-driven inflammation.
3. 03Study focuses on immunomodulation — tuning the body's immune response — at the electrode-tissue interface.
4. 04Relevant to cochlear implants and other auditory neuroprosthetics where electrode-tissue interface quality is critical.
5. 05Research is preclinical/materials science stage; no human or animal implantation outcomes reported in the abstract.

PMID

42287830

DOI

10.1016/j.colsurfb.2026.115911.

Journal

Colloids and Surfaces B: Biointerfaces

Publication type

research_article

Evidence level

na

Population

In vitro neural electrode interface models

Intervention

Electroactive nanostructured polypyrrole coatings with on-demand drug release

Comparator

Uncoated or standard-coated neural electrodes